Table 2.
Acute illness severity and treatments performed of patients with NLVEF compared with HDLVEF
NLVEF | HDLVEF | p value | |
---|---|---|---|
Acute illness indicators | |||
SOFA score | 6 [3–9] | 7 [4–10] | <0.01 |
Sepsis | 1025 (40 %) | 150 (46 %) | 0.04 |
Heart rate maximum, beats/min | 113 [98–130] | 120 [103–139] | <0.01 |
MAP minimum, mmHg | 56 [48–64] | 52 [43–62] | <0.01 |
Temperature maximum (°C) | 37.8 [37.3–38.5] | 37.9 [37.4–38.5] | 0.6 |
Selected laboratory results | |||
WBC max k/μL | 13.3 [9.4–18.3] | 14.6 [10.2–20.5] | <0.01 |
Lactate max mMol/L | 2.1 [1.4–3.7] | 2.6 [1.6–4.8] | <0.01 |
Creat max mg/dL | 1.1 [0.8–1.8] | 1.2 [0.8–2.0] | 0.04 |
Treatments received | |||
Renal replacement | 288 (11 %) | 50 (15 %) | 0.04 |
Vasopressor use | 741 (29 %) | 125 (39 %) | <0.01 |
Mechanical ventilation | 1298 (51 %) | 198 (61 %) | <0.01 |
IV fluids, L (first 24 h) | 2.2 [0.6–5.2] | 2.5 [0.7–5.7] | 0.2 |
HDLVEF hyperdynamic left ventricular ejection fraction on echocardiogram, IV intravenous, MAP mean arterial pressure, NLVEF normal left ventricular ejection fraction on echocardiogram, SOFA Sequential Organ Failure Assessment, WBC white blood cell count
Acute illness severity and treatments performed for patients with NLVEF compared with HDLVEF are displayed as either n (%) or median [IQR]. p Values <0.01 are listed in bold